Sanofi-Aventis Recherche & Developpement

Immune-Mediated Inflammatory Diseases

Clinical research includes ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, and systemic juvenile idiopathic arthritis, with additional interest in coeliac disease and chronic graft versus host disease.

  • Ulcerative colitis
  • Crohn’s disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Chronic graft versus host disease

Research also extends to immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune system diseases.

Dermatology and Allergic Disease

Studies cover atopic dermatitis, psoriasis, hidradenitis suppurativa, pruritus, and chronic rhinosinusitis with nasal polyps, alongside asthma and other respiratory tract diseases.

  • Atopic dermatitis
  • Psoriasis
  • Hidradenitis suppurativa
  • Asthma
  • Chronic rhinosinusitis with nasal polyps

Additional activity includes chronic obstructive pulmonary disease and bronchiectasis within broader respiratory disease research.

Haematology, Oncology, and Plasma Cell Disorders

Research spans multiple myeloma, plasma cell myeloma, relapsed/refractory multiple myeloma, acute myeloid leukemia, acute lymphocytic leukaemia, and myelodysplastic syndrome.

  • Multiple myeloma
  • Acute myeloid leukemia
  • Acute lymphocytic leukaemia
  • Myelodysplastic syndrome
  • Non-small cell lung cancer

Other areas include solid tumours, plasma cell myeloma recurrent, and light-chain amyloidosis.

Neurology and Neuromuscular Disorders

Clinical studies address multiple sclerosis, relapsing multiple sclerosis, progressive multiple sclerosis, amyotrophic lateral sclerosis, and chronic inflammatory demyelinating polyneuropathy.

  • Multiple sclerosis
  • Amyotrophic lateral sclerosis
  • Chronic inflammatory demyelinating polyneuropathy
  • Polyneuropathy
  • Neurological disorders

Research also includes inflammatory demyelinating polyradiculoneuropathy and broader nervous system diseases.

Metabolic, Genetic, and Rare Diseases

Work in this area includes type 1 diabetes mellitus, Fabry disease, Gaucher’s disease type III, glycogen storage disease type II, and achondroplasia.

  • Type 1 diabetes mellitus
  • Fabry disease
  • Gaucher’s disease type III
  • Achondroplasia
  • Congenital, hereditary and neonatal diseases

Additional interest is shown in hemophilia, transplant rejection, Usher’s syndrome, and other nutritional and metabolic diseases.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia France Germany +9
  • A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    Germany Spain
  • A Study of SAR445399 in Adults Aged 18‑80 with Non‑cystic Fibrosis Bronchiectasis

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands Poland Spain
  • Study on Long-Term Safety of Tolebrutinib for Patients with Relapsing or Progressive Multiple Sclerosis

    Not yet recruiting

    3 1 1
    Denmark The Netherlands
  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +8
  • A study to assess how SAR443820 is absorbed, broken down and removed by the body in healthy adult men

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands